TransCode Therapeutics Q4 2024 Earnings WiderthanExpected Loss Reflects ClinicalStage Investment CBAT Q1 2026 Earnings EPS Misses Consensus as Losses Deepen RDW Q1 2026 Earnings EPS Misses Estimates Sharply Yet Stock Surges on Strategic Developments PAGP Q1 2026 Earnings Massive EPS Surprise Highlights Resilient Midstream Operations CCAP Q1 2026 Earnings Narrow EPS Miss Amid Steady Portfolio Performance DAWN Q4 2025 Earnings WiderThanExpected Loss As PreRevenue Biotech Advances Pipeline